Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease

American Journal of Human Genetics

Volumn 74, Issue 6, 2004, Pages 1121-1127

  Van Der Walt, Joelle M ^a   Noureddine, Maher A ^a   Kittappa, Raja ^b   Hauser, Michael A ^a   Scott, William K ^a   McKay, Ron ^b   Zhang, Fengyu ^a   Stajich, Jeffrey M ^a   Fujiwara, Kenichiro ^a   Scott, Burton L ^a   Pericak Vance, Margaret A ^a   Vance, Jeffery M ^a   Martin, Eden R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; BRAIN DERIVED NEUROTROPHIC FACTOR; CYTOSINE; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 20; GUANINE; THYMINE; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; BRAIN; CELL SURVIVAL; CHROMOSOME 8P; CLINICAL RESEARCH; DISEASE ASSOCIATION; DOPAMINERGIC NERVE CELL; FAMILY; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SCREENING; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN GENOME; INTRON; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PEDIGREE; PRIORITY JOURNAL; PUBLICATION; RISK FACTOR; SEQUENCE HOMOLOGY; SUBSTANTIA NIGRA;

EID: 2442642599     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/421052     Document Type: Article

References (23)

1. Abecasis GR, Cookson WO (2000) GOLD - graphical overview of linkage disequilibrium. Bioinformatics 16:182-183
2. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 57:289-300
3. Conne B, Stutz A, Vassalli JD (2000) The 3′ untranslated region of messenger RNA: a molecular "hotspot" for pathology? Nat Med 6:637-641
4. Dekker MC, Bonifati V, van Duijn C (2003) Parkinson's disease: piecing together a genetic jigsaw. Brain 126:1722-1733
5. Dono R (2003) Fibroblast growth factors as regulators of central nervous system development and function. Am J Physiol Regul Integr Comp Physiol 284:R867-R881
6. Fahn S, Elton RL, Members of the UPDRS Development Committee (1987) Unified Parkinson's disease rating scale. In Fahn S, Marsden CD, Calne DB, et al (eds) Recent developments in Parkinson's disease. MacMillan Health Care Information, Florham Park, NJ, pp 153-164
7. Hauser MA, Li YJ, Takeuchi S, Walters R, Noureddine M, Maready M, Darden T, Hulette C, Martin E, Hauser E, Xu H, Schmechel D, Stenger JE, Dietrich F, Vance J (2003) Genomic convergence: identifying candidate genes for Parkinson's disease by combining serial analysis of gene expression and genetic linkage. Hum Mol Genet 15:671-677
8. Haynes C, Speer MC, Peedin M, Roses AD, Haines JL, Vance JM, and Pericak-Vance MA (1995) PEDIGENE: a comprehensive data management system to facilitate efficient and rapid disease gene mapping. Am J Hum Genet Suppl 57: A193
9. Horvath S, Xu X, Lake SL, Silverman EK, Weiss ST, Laird NM (2004) Family-based tests for associating haplotypes with general phenotype data: application to asthma genetics. Genet Epidemiol 26:61-69
10. Jeffers M, Shimkets R, Prayaga S, Boldog F, Yang M, Burgess C, Fernandes E, Rittman B, Shimkets J, LaRochelle WJ, Lichenstein HS (2001) Identification of a novel human fibroblast growth factor and characterization of its role in oncogenesis. Cancer Res 61:3131-3138
11. Kirikoshi H, Sagara N, Saitoh T, Tanaka K, Sekihara H, Shiokawa K, Katoh M (2000) Molecular cloning and characterization of human FGF-20 on chromosome 8p21.3-p22. Biochem Biophys Res Commun 274:337-343
12. Lenhard T, Schober A, Suter-Crazzolara C, Unsicker K (2002) Fibroblast growth factor-2 requires glial-cell-line-derived neurotrophic factor for exerting its neuroprotective actions on glutamate-lesioned hippocampal neurons. Mol Cell Neurosci 20:181-197
13. Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130-1132
14. Martin ER, Bass MP, Gilbert JR, Pericak-Vance MA, Hauser ER (2003) A genotype-based association test for general pedigrees: the genotype-PDT. Genet Epidemiol 25:203-213
15. Martin ER, Bass MP, Kaplan NL (2001) Correcting for a potential bias in the pedigree disequilibrium test. Am J Hum Genet 68:1065-1067
16. Martin ER, Monks SA, Warren LL, Kaplan NL (2000) A test for linkage and association in general pedigrees: the pedigree disequilibrium test. Am J Hum Genet 67:146-154
17. Nicholas KB, Nicholas HB Jr, Deerfield DW II (1997) Gene-Doc: analysis and visualization of genetic variation. EMB-NEW.NEWS 4:14
18. Ohmachi S, Mikami T, Konishi M, Miyake A, Itoh N (2003) Preferential neurotrophic activity of fibroblast growth factor-20 for dopaminergic neurons through fibroblast growth factor receptor-1c. J Neurosci Res 72:436-443
19. Ohmachi S, Watanabe Y, Mikami T, Kusu N, Ibi T, Akaike A, Itoh N (2000) FGF-20, a novel neurotrophic factor, preferentially expressed in the substantia nigra pars compacta of rat brain. Biochem Biophys Res Commun 277:355-360
20. Pankratz N, Nichols WC, Uniacke SK, Halter C, Murrell J, Rudolph A, Shults CW, Conneally PM, Foroud T, The Parkinson Study Group (2003) Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families. Hum Mol Genet 12:2599-2608
21. Pearson WR, Lipman DJ (1988) Improved tools for biological sequence comparison. Proc Natl Acad Sci USA 85:2444-2448
22. Rideout HJ, Dietrich P, Savalle M, Dauer WT, Stefanis L (2003) Regulation of α-synuclein by bFGF in cultured ventral midbrain dopaminergic neurons. J Neurochem 84:803-813
23. Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons K, Pahwa R, et al (2001) Complete genomic screen in Parkinson disease: evidence for multiple genes. JAMA 286:2239-2244